Global Haemophilia Treatment Market Research Report 2023

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.

The global Haemophilia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Haemophilia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Haemophilia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Haemophilia Treatment include Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda and CSL Behring, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Haemophilia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilia Treatment.

The Haemophilia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Haemophilia Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Haemophilia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Haemophilia Treatment

1.2 Haemophilia Treatment Segment by Type

1.2.1 Global Haemophilia Treatment Market Value Comparison by Type (2023-2029)

1.2.2 Haemophilia A

1.2.3 Haemophilia B

1.3 Haemophilia Treatment Segment by Application

1.3.1 Global Haemophilia Treatment Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Pharmaceutical Companies

1.3.4 Other

1.4 Global Haemophilia Treatment Market Size Estimates and Forecasts

1.4.1 Global Haemophilia Treatment Revenue 2018-2029

1.4.2 Global Haemophilia Treatment Sales 2018-2029

1.4.3 Global Haemophilia Treatment Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Haemophilia Treatment Sales Market Share by Manufacturers (2018-2023)

2.2 Global Haemophilia Treatment Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Haemophilia Treatment Average Price by Manufacturers (2018-2023)

2.4 Global Haemophilia Treatment Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Haemophilia Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Haemophilia Treatment, Product Type & Application

2.7 Haemophilia Treatment Market Competitive Situation and Trends

2.7.1 Haemophilia Treatment Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Haemophilia Treatment Players Market Share by Revenue

2.7.3 Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Haemophilia Treatment Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Haemophilia Treatment Global Haemophilia Treatment Sales by Region: 2018-2029

3.2.1 Global Haemophilia Treatment Sales by Region: 2018-2023

3.2.2 Global Haemophilia Treatment Sales by Region: 2024-2029

3.3 Global Haemophilia Treatment Global Haemophilia Treatment Revenue by Region: 2018-2029

3.3.1 Global Haemophilia Treatment Revenue by Region: 2018-2023

3.3.2 Global Haemophilia Treatment Revenue by Region: 2024-2029

3.4 North America Haemophilia Treatment Market Facts & Figures by Country

3.4.1 North America Haemophilia Treatment Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Haemophilia Treatment Sales by Country (2018-2029)

3.4.3 North America Haemophilia Treatment Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Haemophilia Treatment Market Facts & Figures by Country

3.5.1 Europe Haemophilia Treatment Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Haemophilia Treatment Sales by Country (2018-2029)

3.5.3 Europe Haemophilia Treatment Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Haemophilia Treatment Market Facts & Figures by Country

3.6.1 Asia Pacific Haemophilia Treatment Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Haemophilia Treatment Sales by Country (2018-2029)

3.6.3 Asia Pacific Haemophilia Treatment Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Haemophilia Treatment Market Facts & Figures by Country

3.7.1 Latin America Haemophilia Treatment Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Haemophilia Treatment Sales by Country (2018-2029)

3.7.3 Latin America Haemophilia Treatment Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Haemophilia Treatment Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Haemophilia Treatment Sales by Country (2018-2029)

3.8.3 Middle East and Africa Haemophilia Treatment Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Haemophilia Treatment Sales by Type (2018-2029)

4.1.1 Global Haemophilia Treatment Sales by Type (2018-2023)

4.1.2 Global Haemophilia Treatment Sales by Type (2024-2029)

4.1.3 Global Haemophilia Treatment Sales Market Share by Type (2018-2029)

4.2 Global Haemophilia Treatment Revenue by Type (2018-2029)

4.2.1 Global Haemophilia Treatment Revenue by Type (2018-2023)

4.2.2 Global Haemophilia Treatment Revenue by Type (2024-2029)

4.2.3 Global Haemophilia Treatment Revenue Market Share by Type (2018-2029)

4.3 Global Haemophilia Treatment Price by Type (2018-2029)

5.1 Global Haemophilia Treatment Sales by Application (2018-2029)

5.1.1 Global Haemophilia Treatment Sales by Application (2018-2023)

5.1.2 Global Haemophilia Treatment Sales by Application (2024-2029)

5.1.3 Global Haemophilia Treatment Sales Market Share by Application (2018-2029)

5.2 Global Haemophilia Treatment Revenue by Application (2018-2029)

5.2.1 Global Haemophilia Treatment Revenue by Application (2018-2023)

5.2.2 Global Haemophilia Treatment Revenue by Application (2024-2029)

5.2.3 Global Haemophilia Treatment Revenue Market Share by Application (2018-2029)

5.3 Global Haemophilia Treatment Price by Application (2018-2029)

6.1 Bayer

6.1.1 Bayer Corporation Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Bayer Haemophilia Treatment Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Novo Nordisk

6.2.1 Novo Nordisk Corporation Information

6.2.2 Novo Nordisk Description and Business Overview

6.2.3 Novo Nordisk Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Novo Nordisk Haemophilia Treatment Product Portfolio

6.2.5 Novo Nordisk Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Haemophilia Treatment Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Roche

6.4.1 Roche Corporation Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Roche Haemophilia Treatment Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 Aptevo Therapeutics

6.5.1 Aptevo Therapeutics Corporation Information

6.5.2 Aptevo Therapeutics Description and Business Overview

6.5.3 Aptevo Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Aptevo Therapeutics Haemophilia Treatment Product Portfolio

6.5.5 Aptevo Therapeutics Recent Developments/Updates

6.6 Catalyst BioSciences

6.6.1 Catalyst BioSciences Corporation Information

6.6.2 Catalyst BioSciences Description and Business Overview

6.6.3 Catalyst BioSciences Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Catalyst BioSciences Haemophilia Treatment Product Portfolio

6.6.5 Catalyst BioSciences Recent Developments/Updates

6.7 Dimension Therapeutics

6.6.1 Dimension Therapeutics Corporation Information

6.6.2 Dimension Therapeutics Description and Business Overview

6.6.3 Dimension Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Dimension Therapeutics Haemophilia Treatment Product Portfolio

6.7.5 Dimension Therapeutics Recent Developments/Updates

6.8 Takeda

6.8.1 Takeda Corporation Information

6.8.2 Takeda Description and Business Overview

6.8.3 Takeda Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Takeda Haemophilia Treatment Product Portfolio

6.8.5 Takeda Recent Developments/Updates

6.9 CSL Behring

6.9.1 CSL Behring Corporation Information

6.9.2 CSL Behring Description and Business Overview

6.9.3 CSL Behring Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.9.4 CSL Behring Haemophilia Treatment Product Portfolio

6.9.5 CSL Behring Recent Developments/Updates

6.10 Alnylam Pharmaceuticals

6.10.1 Alnylam Pharmaceuticals Corporation Information

6.10.2 Alnylam Pharmaceuticals Description and Business Overview

6.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Product Portfolio

6.10.5 Alnylam Pharmaceuticals Recent Developments/Updates

7.1 Haemophilia Treatment Industry Chain Analysis

7.2 Haemophilia Treatment Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Haemophilia Treatment Production Mode & Process

7.4 Haemophilia Treatment Sales and Marketing

7.4.1 Haemophilia Treatment Sales Channels

7.4.2 Haemophilia Treatment Distributors

7.5 Haemophilia Treatment Customers

8.1 Haemophilia Treatment Industry Trends

8.2 Haemophilia Treatment Market Drivers

8.3 Haemophilia Treatment Market Challenges

8.4 Haemophilia Treatment Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Haemophilia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Haemophilia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Haemophilia Treatment Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Haemophilia Treatment Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Haemophilia Treatment Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Haemophilia Treatment Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Haemophilia Treatment Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Haemophilia Treatment Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Haemophilia Treatment, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Haemophilia Treatment, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Haemophilia Treatment, Product Type & Application

    Table 12. Global Key Manufacturers of Haemophilia Treatment, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Treatment as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Haemophilia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Haemophilia Treatment Sales by Region (2018-2023) & (K Units)

    Table 18. Global Haemophilia Treatment Sales Market Share by Region (2018-2023)

    Table 19. Global Haemophilia Treatment Sales by Region (2024-2029) & (K Units)

    Table 20. Global Haemophilia Treatment Sales Market Share by Region (2024-2029)

    Table 21. Global Haemophilia Treatment Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Haemophilia Treatment Revenue Market Share by Region (2018-2023)

    Table 23. Global Haemophilia Treatment Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Haemophilia Treatment Revenue Market Share by Region (2024-2029)

    Table 25. North America Haemophilia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Haemophilia Treatment Sales by Country (2018-2023) & (K Units)

    Table 27. North America Haemophilia Treatment Sales by Country (2024-2029) & (K Units)

    Table 28. North America Haemophilia Treatment Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Haemophilia Treatment Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Haemophilia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Haemophilia Treatment Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Haemophilia Treatment Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Haemophilia Treatment Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Haemophilia Treatment Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Haemophilia Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Haemophilia Treatment Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Haemophilia Treatment Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Haemophilia Treatment Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Haemophilia Treatment Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Haemophilia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Haemophilia Treatment Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Haemophilia Treatment Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Haemophilia Treatment Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Haemophilia Treatment Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Haemophilia Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Haemophilia Treatment Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Haemophilia Treatment Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Haemophilia Treatment Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Haemophilia Treatment Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Haemophilia Treatment Sales (K Units) by Type (2018-2023)

    Table 51. Global Haemophilia Treatment Sales (K Units) by Type (2024-2029)

    Table 52. Global Haemophilia Treatment Sales Market Share by Type (2018-2023)

    Table 53. Global Haemophilia Treatment Sales Market Share by Type (2024-2029)

    Table 54. Global Haemophilia Treatment Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Haemophilia Treatment Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Haemophilia Treatment Revenue Market Share by Type (2018-2023)

    Table 57. Global Haemophilia Treatment Revenue Market Share by Type (2024-2029)

    Table 58. Global Haemophilia Treatment Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Haemophilia Treatment Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Haemophilia Treatment Sales (K Units) by Application (2018-2023)

    Table 61. Global Haemophilia Treatment Sales (K Units) by Application (2024-2029)

    Table 62. Global Haemophilia Treatment Sales Market Share by Application (2018-2023)

    Table 63. Global Haemophilia Treatment Sales Market Share by Application (2024-2029)

    Table 64. Global Haemophilia Treatment Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Haemophilia Treatment Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Haemophilia Treatment Revenue Market Share by Application (2018-2023)

    Table 67. Global Haemophilia Treatment Revenue Market Share by Application (2024-2029)

    Table 68. Global Haemophilia Treatment Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Haemophilia Treatment Price (USD/Unit) by Application (2024-2029)

    Table 70. Bayer Corporation Information

    Table 71. Bayer Description and Business Overview

    Table 72. Bayer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Bayer Haemophilia Treatment Product

    Table 74. Bayer Recent Developments/Updates

    Table 75. Novo Nordisk Corporation Information

    Table 76. Novo Nordisk Description and Business Overview

    Table 77. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Novo Nordisk Haemophilia Treatment Product

    Table 79. Novo Nordisk Recent Developments/Updates

    Table 80. Pfizer Corporation Information

    Table 81. Pfizer Description and Business Overview

    Table 82. Pfizer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Pfizer Haemophilia Treatment Product

    Table 84. Pfizer Recent Developments/Updates

    Table 85. Roche Corporation Information

    Table 86. Roche Description and Business Overview

    Table 87. Roche Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Roche Haemophilia Treatment Product

    Table 89. Roche Recent Developments/Updates

    Table 90. Aptevo Therapeutics Corporation Information

    Table 91. Aptevo Therapeutics Description and Business Overview

    Table 92. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Aptevo Therapeutics Haemophilia Treatment Product

    Table 94. Aptevo Therapeutics Recent Developments/Updates

    Table 95. Catalyst BioSciences Corporation Information

    Table 96. Catalyst BioSciences Description and Business Overview

    Table 97. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Catalyst BioSciences Haemophilia Treatment Product

    Table 99. Catalyst BioSciences Recent Developments/Updates

    Table 100. Dimension Therapeutics Corporation Information

    Table 101. Dimension Therapeutics Description and Business Overview

    Table 102. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Dimension Therapeutics Haemophilia Treatment Product

    Table 104. Dimension Therapeutics Recent Developments/Updates

    Table 105. Takeda Corporation Information

    Table 106. Takeda Description and Business Overview

    Table 107. Takeda Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Takeda Haemophilia Treatment Product

    Table 109. Takeda Recent Developments/Updates

    Table 110. CSL Behring Corporation Information

    Table 111. CSL Behring Description and Business Overview

    Table 112. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. CSL Behring Haemophilia Treatment Product

    Table 114. CSL Behring Recent Developments/Updates

    Table 115. Alnylam Pharmaceuticals Corporation Information

    Table 116. Alnylam Pharmaceuticals Description and Business Overview

    Table 117. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Alnylam Pharmaceuticals Haemophilia Treatment Product

    Table 119. Alnylam Pharmaceuticals Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Haemophilia Treatment Distributors List

    Table 123. Haemophilia Treatment Customers List

    Table 124. Haemophilia Treatment Market Trends

    Table 125. Haemophilia Treatment Market Drivers

    Table 126. Haemophilia Treatment Market Challenges

    Table 127. Haemophilia Treatment Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Haemophilia Treatment

    Figure 2. Global Haemophilia Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Haemophilia Treatment Market Share by Type in 2022 & 2029

    Figure 4. Haemophilia A Product Picture

    Figure 5. Haemophilia B Product Picture

    Figure 6. Global Haemophilia Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Haemophilia Treatment Market Share by Application in 2022 & 2029

    Figure 8. Hospital

    Figure 9. Pharmaceutical Companies

    Figure 10. Other

    Figure 11. Global Haemophilia Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Haemophilia Treatment Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Haemophilia Treatment Sales (2018-2029) & (K Units)

    Figure 14. Global Haemophilia Treatment Average Price (USD/Unit) & (2018-2029)

    Figure 15. Haemophilia Treatment Report Years Considered

    Figure 16. Haemophilia Treatment Sales Share by Manufacturers in 2022

    Figure 17. Global Haemophilia Treatment Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Haemophilia Treatment Players: Market Share by Revenue in 2022

    Figure 19. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Haemophilia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Haemophilia Treatment Sales Market Share by Country (2018-2029)

    Figure 22. North America Haemophilia Treatment Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Haemophilia Treatment Sales Market Share by Country (2018-2029)

    Figure 26. Europe Haemophilia Treatment Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Haemophilia Treatment Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Haemophilia Treatment Revenue Market Share by Region (2018-2029)

    Figure 34. China Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Taiwan Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Haemophilia Treatment Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Haemophilia Treatment Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Haemophilia Treatment Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Haemophilia Treatment Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. U.A.E Haemophilia Treatment Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Haemophilia Treatment by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Haemophilia Treatment by Type (2018-2029)

    Figure 56. Global Haemophilia Treatment Price (USD/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Haemophilia Treatment by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Haemophilia Treatment by Application (2018-2029)

    Figure 59. Global Haemophilia Treatment Price (USD/Unit) by Application (2018-2029)

    Figure 60. Haemophilia Treatment Value Chain

    Figure 61. Haemophilia Treatment Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed